Maud Marques

1.2k total citations
26 papers, 914 citations indexed

About

Maud Marques is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Maud Marques has authored 26 papers receiving a total of 914 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 10 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Maud Marques's work include RNA modifications and cancer (6 papers), Cancer Genomics and Diagnostics (5 papers) and PARP inhibition in cancer therapy (5 papers). Maud Marques is often cited by papers focused on RNA modifications and cancer (6 papers), Cancer Genomics and Diagnostics (5 papers) and PARP inhibition in cancer therapy (5 papers). Maud Marques collaborates with scholars based in Canada, United States and Brazil. Maud Marques's co-authors include Michael Witcher, Luc Gaudreau, Liette Laflamme, Khalid Hilmi, Tatiana Shorstova, Tiejun Zhao, Alain Gervais, Qiang Sun, Moulay A. Alaoui‐Jamali and Sonia V. del Rincón and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Clinical Oncology.

In The Last Decade

Maud Marques

23 papers receiving 908 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Maud Marques Canada	17	647	202	108	86	86	26	914
Rit Vatsyayan United States	22	634 1.0×	178 0.9×	111 1.0×	43 0.5×	86 1.0×	33	1.1k
Jennifer T. Fox United States	13	511 0.8×	187 0.9×	131 1.2×	121 1.4×	40 0.5×	29	885
A‐Mei Huang Taiwan	23	735 1.1×	232 1.1×	194 1.8×	56 0.7×	114 1.3×	51	1.2k
Laura M. Vargas‐Roig Argentina	17	561 0.9×	235 1.2×	265 2.5×	83 1.0×	78 0.9×	32	977
Arunkumar Arumugam United States	14	429 0.7×	227 1.1×	204 1.9×	40 0.5×	63 0.7×	27	717
Simona Piaggi Italy	20	386 0.6×	258 1.3×	99 0.9×	68 0.8×	43 0.5×	47	1.0k
Daniele G. Soares France	14	439 0.7×	277 1.4×	143 1.3×	38 0.4×	73 0.8×	29	820
Debra L. Bemis United States	13	557 0.9×	189 0.9×	165 1.5×	69 0.8×	43 0.5×	21	1.0k
Qinghua Cui China	16	536 0.8×	202 1.0×	234 2.2×	36 0.4×	123 1.4×	28	968
Emilia L. Lim Canada	10	519 0.8×	116 0.6×	225 2.1×	85 1.0×	26 0.3×	15	809

Countries citing papers authored by Maud Marques

Since Specialization

Citations

This map shows the geographic impact of Maud Marques's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maud Marques with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maud Marques more than expected).

Fields of papers citing papers by Maud Marques

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maud Marques. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maud Marques. The network helps show where Maud Marques may publish in the future.

Co-authorship network of co-authors of Maud Marques

This figure shows the co-authorship network connecting the top 25 collaborators of Maud Marques. A scholar is included among the top collaborators of Maud Marques based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maud Marques. Maud Marques is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pataky, Reka, Maud Marques, Karen Gambaro, et al.. (2024). Real-World Safety of Niraparib for Maintenance Treatment of Ovarian Cancer in Canada. Current Oncology. 31(6). 3591–3602. 1 indexed citations

Gambaro, Karen, Maud Marques, Cyrla Hoffert, et al.. (2023). A Phase II Exploratory Study to Identify Biomarkers Predictive of Clinical Response to Regorafenib in Patients with Metastatic Colorectal Cancer Who Have Failed First-Line Therapy. International Journal of Molecular Sciences. 25(1). 43–43.

Gambaro, Karen, Arif Awan, Mahmoud Abdelsalam, et al.. (2023). Third-line treatment patterns in HER2-positive metastatic breast cancer: a retrospective analysis of real-world data in Canada. Journal of Pharmacy & Pharmaceutical Sciences. 26. 12078–12078.

Marques, Maud, et al.. (2020). Abstract 6494: Personalize My Treatment (PMT): A pan-Canadian initiative integrating precision oncology across Canada - PMT-001 pilot project. Cancer Research. 80(16_Supplement). 6494–6494. 2 indexed citations

Marques, Maud, Lise Tremblay, Nicole Bouchard, et al.. (2019). Analysis of the Genomic Landscape in ALK+ NSCLC Patients Identifies Novel Aberrations Associated with Clinical Outcomes. Molecular Cancer Therapeutics. 18(9). 1628–1636. 20 indexed citations

Shorstova, Tatiana, Maud Marques, Jie Su, et al.. (2019). SWI/SNF-Compromised Cancers Are Susceptible to Bromodomain Inhibitors. Cancer Research. 79(10). 2761–2774. 52 indexed citations

Marques, Maud, Maïka Jangal, Lichun Wang, et al.. (2018). Oncogenic activity of poly (ADP-ribose) glycohydrolase. Oncogene. 38(12). 2177–2191. 25 indexed citations

Philip, Charles‐André, Ido Laskov, Marie‐Claude Beauchamp, et al.. (2017). Inhibition of PI3K-AKT-mTOR pathway sensitizes endometrial cancer cell lines to PARP inhibitors. BMC Cancer. 17(1). 638–638. 81 indexed citations

Wan, Ji, Yoshihiko Fujita, Jagpreet S. Nanda, et al.. (2017). Competition between translation initiation factor eIF5 and its mimic protein 5MP determines non-AUG initiation rate genome-wide. Nucleic Acids Research. 45(20). 11941–11953. 59 indexed citations

10.

Saad, Amine, Krikor Bijian, Sabrina Daniela da Silva, et al.. (2016). Insights into a novel nuclear function for Fascin in the regulation of the amino-acid transporter SLC3A2. Scientific Reports. 6(1). 36699–36699. 24 indexed citations

11.

Shorstova, Tatiana, et al.. (2016). Epigenetic silencing of tumor suppressor genes: Paradigms, puzzles, and potential. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1865(2). 275–288. 149 indexed citations

12.

Manteghi, Sanaz, Marie‐Claude Gingras, Dmitri Kharitidi, et al.. (2016). Haploinsufficiency of the ESCRT Component HD-PTP Predisposes to Cancer. Cell Reports. 15(9). 1893–1900. 37 indexed citations

13.

Zhao, Tiejun, Qiang Sun, Maud Marques, & Michael Witcher. (2015). Anticancer Properties ofPhyllanthus emblica(Indian Gooseberry). Oxidative Medicine and Cellular Longevity. 2015. 1–7. 75 indexed citations

14.

Marques, Maud, Marie‐Claude Beauchamp, Hubert Fleury, et al.. (2015). Chemotherapy reduces PARP1 in cancers of the ovary: implications for future clinical trials involving PARP inhibitors. BMC Medicine. 13(1). 217–217. 16 indexed citations

15.

Marques, Maud, et al.. (2014). Analysis of changes to mRNA levels and CTCF occupancy upon TFII-I knockdown. Genomics Data. 4. 17–21. 3 indexed citations

16.

Zhao, Tiejun, et al.. (2014). Gallotannin Imposes S Phase Arrest in Breast Cancer Cells and Suppresses the Growth of Triple-Negative Tumors In Vivo. PLoS ONE. 9(3). e92853–e92853. 25 indexed citations

17.

Marques, Maud, et al.. (2014). Low levels of 3,3′-diindolylmethane activate estrogen receptor α and induce proliferation of breast cancer cells in the absence of estradiol. BMC Cancer. 14(1). 524–524. 37 indexed citations

18.

Marques, Maud, Liette Laflamme, & Luc Gaudreau. (2013). Estrogen receptor α can selectively repress dioxin receptor-mediated gene expression by targeting DNA methylation. Nucleic Acids Research. 41(17). 8094–8106. 67 indexed citations

19.

Gervais, Alain, Maud Marques, & Luc Gaudreau. (2010). PCRTiler: automated design of tiled and specific PCR primer pairs. Nucleic Acids Research. 38(suppl_2). W308–W312. 18 indexed citations

20.

Marques, Maud, Liette Laflamme, Alain Gervais, & Luc Gaudreau. (2010). Reconciling the positive and negative roles of histone H2A.Z in gene transcription. Epigenetics. 5(4). 267–272. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact